Rivaroxaban for the treatment of deep vein thrombosis and prevention of recurrent deep vein thrombosis and pulmonary embolism

Technology appraisal guidance
Reference number: TA261
Published: 25 July 2012

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix A - RPP decision paper - June 2015

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix A - RPP decision paper - June 2015

Venous thromboembolism (treatment and long term secondary prevention) - rivaroxaban: appendix A - RPP decision paper - June 2015
24 June 2015
(65.99 Kb 19 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 22 June 2015